Klinikum St. Georg, Clinics of Anesthesiology, Critical Care and Pain Therapy
Leipzig, Saxony, 04129, Germany
NCT Number: NCT00484796
Hypothesis: Trigeminus-evoked somatosensory potentials (TRI-SEP) may be used as an alternative technique to medianus-evoked somatosensory potentials (MED-SEP) in patients undergoing elective carotid surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Leipzig, Saxony, 04129, Germany
For CNS-monitoring somatosensory-evoked responses ba electrical stimulation of the contralateral median nerve are established: A reduction of amplitude and a delay in latency may represent a sensible marker of imminent cerebral ischemia. This study will evaluate a new concept by using trigeminal nerve evoked somatosensory evoked potentials in comparison to the established MED-SEP. Beside the comparison of two methods of neuromonitoring, this study will investigate the neurological long-term outcome (90-day evaluation) with different neuropsychological tests for the detection of cognitive deficits.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
intraoperative neurophysiological monitoring
intraoperative neurophysiologic monitoring
neurological short- and longterm outcome
Time frame: intraoperative, 28 days, and 60 days after surgery
Klinikum St. Georg gGmbH
Other
Comparison of Trigeminus-evoked Somatosensory Potentials (TRI-SEP) and Medianus-evoked Somatosensory Potentials (MED-SEP) in Patients Undergoing Carotid Surgery
Acronym: TRISEP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06359756
Brain Diseases, Cardiovascular Diseases
Belgrade, Serbia
View Trial DetailsNCT01713491
Adverse Effect of Thrombolytic Drugs, Brain Diseases
Lille, France
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial Details